Clinical Trial Update: Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia [Phase 1]

View source ↗

Summary

Phase 1 feasibility and safety study evaluating umbilical cord blood transfusion for treating neonatal cerebral ischemia and anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Ischemia of the Newborn
• Hypoxic-ischemic Encephalopathy
• Neonatal Anemia
• Neonatal Hypoxia

Drugs mentioned

• Umbilical cord blood transfusion (Umbilical cord blood transfusion)

Snippet

Sponsor: Mononuclear Therapeutics Ltd. | Conditions: Hypoxic-Ischemic Encephalopathy, Hypoxia Neonatal | Phase 1 | Status: UNKNOWN